Gastroenterology

Bioengineered approach shows promise in ulcerative colitis

By taking advantage of mechanisms that allow cancer cells to evade immune attack, UT Southwestern Medical Center researchers have developed a new strategy in animal models that has potential for treating ulcerative colitis. ...

Oncology & Cancer

The role of fibronectin in BRAF-mutant thyroid cancer treatment

New research overseen by University of Colorado Cancer Center member Rebecca Schweppe, Ph.D., could lead to improved treatment for people with thyroid cancer characterized by a mutation in the BRAF gene—a mutation also ...

Oncology & Cancer

Cancer drug restores immune system's ability to fight tumors

A new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The University of Texas at Austin has found. In mouse models of melanoma, bladder cancer, leukemia and colon ...

Oncology & Cancer

Study reveals colon tumor location matters for metastatic disease

Colon cancers that spread to the liver may be substantially different depending on the location where cancerous cells originate, according to new research. The study led by Yale Cancer Center researchers at Yale School of ...

Medical research

Blocking proteins could pull the plug on power for colon tumors

Through study findings published in Cell Reports, a team of scientists at VCU Massey Cancer Center has discovered a previously unknown interaction between proteins that is responsible for supplying energy to tumor cells and ...

page 1 from 37